IBM Retirement Fund’s Acceleron Pharma XLRN Stock Holding History

IBM Retirement Fund’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,492	Closed	-$257K	–	740
2021 Q3	$257K	Buy	+1,492	New	+$195K	0.02%	622
2021 Q2	–	Sell	-1,755	Closed	-$238K	–	802
2021 Q1	$238K	Sell	1,755 -137	-7%	-$17.7K	0.02%	703
2020 Q4	$242K	Buy	+1,892	New	+$222K	0.02%	692
2015 Q3	–	Sell	-9,375	Closed	-$297K	–	1013
2015 Q2	$297K	Hold	9,375	–	–	0.01%	1025
2015 Q1	$357K	Hold	9,375	–	–	0.01%	995
2014 Q4	$365K	Buy	+9,375	New	+$327K	0.01%	999

IBM Retirement Fund's XLRN Position: Q4 2021 in Review

IBM Retirement Fund sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,492 shares — an estimated $257K sold.

IBM Retirement Fund first reported a position in XLRN in Q4 2014 and held it in 6 quarters. The position peaked at $365K in Q4 2014. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

IBM Retirement Fund reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
IBM Retirement Fund sold 1,492 Acceleron Pharma shares in Q4 2021, an estimated $257K.
IBM Retirement Fund first reported a position in Acceleron Pharma in Q4 2014 and held it in 6 quarters.
IBM Retirement Fund's Acceleron Pharma position peaked at $365K in Q4 2014.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on IBM Retirement Fund's 13F filing for Q4 2021, filed 19 Jan 2022.